The association of nicotine replacement therapy with mortality in a medical intensive care unit

Critical Care Medicine

Volumn 35, Issue 6, 2007, Pages 1517-1521

  Lee, Amy H ^a   Afessa, Bekele ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute Physiology and Chronic Health Evaluation; Intensive care; Length of stay; Mortality; Nicotine; Smoking

Indexed keywords

NICOTINE;

ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SMOKING; TERTIARY HEALTH CARE;

EID: 34249309233     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000266537.86437.38     Document Type: Article

References (40)

1. Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362:847-852
2. Centers for Disease Control and Prevention: Behavioral risk factor surveillance system survey data. Available at: www.cdc.gov. Accessed September 21, 2006
3. Anthonisen NR, Skeans MA, Wise RA, et al: The effects of a smoking cessation intervention on 14.5-year mortality: A randomized clinical trial. Ann Intern Med 2005; 142:233-239
4. Fagerstrom K: The epidemiology of smoking: Health consequences and benefits of cessation. Drugs 2002; 62(Suppl 2):1-9
5. Henningfield JE, Miyasato K, Jasinski DR: Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 1985; 234:1-12
6. Hurt RD, Robertson CR: Prying open the door to the tobacco industry's secrets about nicotine: The Minnesota tobacco trial. JAMA 1998; 280:1173-1181
7. World Health Organization: Mayo report on addressing the worldwide tobacco epidemic through effective, evidence-based treatment. Available at: www.who.int/en. Accessed September 21, 2006
8. Joseph AM, Norman SM, Ferry LH, et al: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335:1792-1798
9. Silagy C, Lancaster T, Stead L, et al: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3):CD000146
10. Murray RP, Bailey WC, Daniels K, et al: Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996; 109:438-445
11. Kimmel SE, Berlin JA, Miles C, et al: Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001; 37:1297-1302
12. Ludvig J, Miner B, Eisenberg MJ: Smoking cessation in patients with coronary artery disease. Am Heart J 2005; 149:565-572
13. Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol 1997; 29:1422-1431
14. Ford CL, Zlabek JA: Nicotine replacement therapy and cardiovascular disease. Mayo Clin Proc 2005; 80:652-656
15. Hubbard R, Lewis S, Smith C, et al: Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 2005; 14:416-421
16. Fishbein L, O'Brien P, Hutson A, et al: Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. J Investig Med 2000; 48:435-440
17. Tzivoni D, Keren A, Meyler S, et al: Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998; 12:239-244
18. Lewis SF, Piasecki TM, Fiore MC, et al: Transdermal nicotine replacement for hospitalized patients: A randomized clinical trial. Prev Med 1998; 27:296-303
19. Meine TJ, Patel MR, Washam JB, et al: Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005; 95:976-978
20. Mayer SA, Chong JY, Ridgway E, et al: Delirium from nicotine withdrawal in neuro-ICU patients. Neurology 2001; 57:551-553
21. Tran-Van D, Herve Y, Labadie P, et al: Restlessness in intensive care unit: Think to the nicotinic withdrawal syndrome. Ann Fr Anesth Reanim 2004; 23:604-606
22. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
23. Cullen DJ, Civetta JM, Briggs BA, et al: Therapeutic intervention scoring system: A method for quantitative comparison of patient care. Crit Care Med 1974; 2:57-60
24. Keene AR, Cullen DJ: Therapeutic intervention scoring system: Update 1983. Crit Care Med 1983; 11:1-3
25. Zimmerman JE, Wagner DP, Knaus WA, et al: The use of risk predictions to identify candidates for intermediate care units. Implications for intensive care utilization and cost. Chest 1995; 108:490-499
26. Rubenfeld GD, Angus DC, Pinsky MR, et al: Outcomes research in critical care: Results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med 1999; 160:358-367
27. Marshall JC, Vincent JL, Guyatt G, et al: Outcome measures for clinical research in sepsis: A report of the Second Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005; 33:1708-1716
28. Benowitz NL: Basic cardiovascular research and its implications for the medicinal use of nicotine. J Am Coll Cardiol 2003; 41:497-498
29. Benowitz NL: The role of nicotine in smoking-related cardiovascular disease. Prev Med 1997; 26:412-417
30. Puura A: Transdermal nicotine increases heart rate after endotracheal intubation. Methods Find Exp Clin Pharmacol 2003; 25:383-385
31. Najem B, Houssiere A, Pathak A, et al: Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension 2006; 47:1162-1167
32. Beeman JA, Hunter WC: Fatal nicotine poisoning: A report of 24 cases. Arch Pathol 1937; 24:481-485
33. Manoguerra AS, Freeman D: Acute poisoning from the ingestion of Nicotiana glauca. J Toxicol Clin Toxicol 1982; 19:861-864
34. Working Group for the Study of Transdermal Nicotine in Patients With Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154:989-995
35. Mahmarian JJ, Moye LA, Nasser GA, et al: Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997; 30:125-130
36. Reid R, Pipe A, Higginson L, et al: Stepped care approach to smoking cessation in patients hospitalized for coronary artery disease. J Cardiopulm Rehabil 2003; 23:176-182
37. Campbell IA, Prescott RJ, Tjeder-Burton SM: Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 1991; 85:155-157
38. Ang R, Wroe S, Manji H, et al: Nicotine replacement therapy and ischaemic stroke. Hosp Med 2005; 66:366-367
39. Mathew TP, Herity NA: Acute myocardial infarction soon after nicotine replacement therapy. QJM 2001; 94:503-504
40. Warner DO, Patten CA, Ames SC, et al: Effect of nicotine replacement therapy on stress and smoking behavior in surgical patients. Anesthesiology 2005; 102:1138-1146